Literature DB >> 5124532

Bile acid sulfates. I. Synthesis of lithocholic acid sulfates and their identification in human bile.

R H Palmer, M G Bolt.   

Abstract

Sulfate esters of lithocholic, glycolithocholic, and taurolithocholic acids were synthesized using sulfur trioxide in pyridine; they were purified by crystallization from methanol or ethanol as the diammonium salts, and their chemical compositions, infared spectra, and chromatographic behavior were determined. Strong alkaline hydrolysis of these sulfates, as commonly performed during quantitative and qualitative analyses of conjugated bile salts, was found to result in a number of degradation products, presumably through disruption of the C-O bond of the hydroxyl group and conversion of the original steroid to isolithocholate and other (possibly olefinic) compounds. After oral administration of lithocholate-(14)C to three patients with cholelithiasis, radioactive metabolites having the chromatographic properties of sulfated lithocholates were isolated from bile and, confirming a preliminary report (1), were identified as sulfated glycolithocholate and taurolithocholate by their characteristic chromatographic mobilities during a series of specific hydrolytic procedures and by crystallizing them to constant specific activities with the synthetic sulfates. The fraction of endogenous lithocholate present in bile as the sulfate was calculated for two patients by isotope dilution and was shown to be 41% and 75% of the total. Sulfation can be expected to affect the physiological and pharmacological properties of lithocholates and may, therefore, influence the toxic properties of these compounds.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5124532

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

1.  Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat.

Authors:  F Kuipers; M Enserink; R Havinga; A B van der Steen; M J Hardonk; J Fevery; R J Vonk
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Bile acid excretion: the alternate pathway in the hamster.

Authors:  R Galeazzi; N B Javitt
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

Review 3.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

4.  Adsorption of Lithocholic Acid to Fusarium equiseti M41 as an Essential Process in Its Conversion to Ursodeoxycholic Acid.

Authors:  Takuya Nihira; Toshiki Nishino; Masao Maehara; Songsri Kulprecha; Toshiomi Yoshida; Hisaharu Taguchi
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

5.  Lithocholic acid in human liver: identification of epsilon-lithocholyl lysine in tissue protein.

Authors:  P P Nair; A I Mendeloff; M Vocci; J Bankoski; M Gorelik; G Herman; R Plapinger
Journal:  Lipids       Date:  1977-11       Impact factor: 1.880

6.  Will the real bile acid sulfotransferase please stand up? Identification of Sult2a8 as a major hepatic bile acid sulfonating enzyme in mice.

Authors:  Paul A Dawson; Kenneth D R Setchell
Journal:  J Lipid Res       Date:  2017-04-28       Impact factor: 5.922

7.  Synthesis of bile acid monosulphates by the isolated perfused rat kidney.

Authors:  J A Summerfield; J L Gollan; B H Billing
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

8.  The inhibition of lysozyme by bile acids.

Authors:  G Vantrappen; A Y Ghoos; T Peeters
Journal:  Am J Dig Dis       Date:  1976-07

9.  Chenodeoxycholic acid induced liver injury in pregnant and neonatal baboons.

Authors:  C K McSherry; K P Morrissey; R L Swarm; P S May; W H Niemann; F Glenn
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

10.  Bile acid composition of rainbow trout, Salmo gairdneri.

Authors:  J E Denton; M K Yousef; I M Yousef
Journal:  Lipids       Date:  1974-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.